ABBOTT INDIA LTD. - 500488 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- Krupa AnandparaDesignation :- Company Secretary and Compliance Officer ABBOTT INDIA LTD. - 500488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed, Certificate issued by KFin Technologies Private Limited, Registrar and Share Agent of the Company for the third quarter ended December 31, 2020. Kindly acknowledge receipt of the same. ABBOTT INDIA LTD. - 500488 - Closure of Trading Window
This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the shares of the Company by the Designated Persons and their immediate relatives shall be closed from tomorrow i.e. Thursday, December 31, 2020 and the same shall reopen after 48 hours from the declaration of Unaudited Financial Results of the Company for the third quarter ended on December 31, 2020. You are requested to take the same on record. ABBOTT INDIA LTD. - 500488 - Disclosure Under Regulation 23(9) Of The SEBI (LODR) 2015
Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2020. The above disclosure is also available on the website of the Company i.e. www.abbott.co.in This is for your information and record.
Buy Abbott India: target of Rs 19,425: Sharekhan
Sharekhan is bullish on Abbott India recommended buy rating on the stock with a target price of Rs 19,425 in its research report dated November 11, 2020. ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the newspaper cuttings of the Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2020 published in Business Standard (All Editions) and Loksatta on Thursday, November 12, 2020. This is for your information and record.
Abbott India Q2 net profit up 1% to Rs 181 crore
Revenue from operations remained flat at Rs 1,054.85 crore during the quarter under review as compared with Rs 1,054.80 crore in the year-ago period, Abbott India said in a regulatory filing. ABBOTT INDIA LTD. - 500488 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2020
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2020, approved by the Board of Directors at its Meeting held today i.e., Wednesday, November 11, 2020 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 1.30 pm. Kindly acknowledge the receipt of the same. ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed the copies of Public Notice published as per Regulation 47 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in Business Standard (All Editions) and Loksatta on Monday, November 2, 2020 in connection with the Meeting of the Board of Directors to be held on Wednesday, November 11, 2020. This is for your information and records. ABBOTT INDIA LTD. - 500488 - Board Meeting Intimation for Approval Of The Text Of Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended On September 30, 2020.
ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve the text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2020. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2019, the Trading Window of the Company remains closed from Wednesday, September 30, 2020 to Friday, November 13, 2020 (both days inclusive). Kindly acknowledge the receipt of the same.